Literature DB >> 598011

Male pseudohermaphroditism with gynaecomastia due to testicular 17-ketosteroid reductase deficiency.

F Ademola Akesode, W J Meyer, C J Migeon.   

Abstract

A 28-year-old male pseudohermaphrodite with gynaecomastia was raised as a female until the age of 17 years, at which time he developed masculine features (deepening of the voice, development of facial hair, male distribution of body hair and male body habitus) and assumed a male gender role. He had a small phallus with perineal urethra, absence of labioscrotal fusion, presence of vaginal pouch and undescended testes. The testicular biopsy showed hyalinization of the tubular basement membrane, lack of spermatogenesis and hyperplastic Leydig cells. Baseline peripheral plasma studies showed androstenedione concentrations ten times normal, low testosterone, elevated oestrone and elevated gonadotrophins. The in vitro incubation of testicular tissue showed no significant conversion of androstenedione to testosterone. However, two types of peripheral tissues, skin fibroblasts and erythrocytes, had a normal conversion, as did the body overall as measured by the technique of androstenedione constant infusion. These studies demonstrate that the 17-ketosteroid reductase deficiency of the patient was limited to the testes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 598011     DOI: 10.1111/j.1365-2265.1977.tb01336.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

Review 1.  Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma.

Authors:  A D Fisher; J Ristori; E Fanni; G Castellini; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-06-10       Impact factor: 4.256

Review 2.  Endocrine findings in male pseudohermaphroditism.

Authors:  M Zachmann
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

Review 3.  XY females with enzyme deficiencies of steroid metabolism. A brief review.

Authors:  K Madan; J Schoemaker
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

4.  Physical and hormonal evaluation of transsexual patients during hormonal therapy.

Authors:  W J Meyer; J W Finkelstein; C A Stuart; A Webb; E R Smith; A F Payer; P A Walker
Journal:  Arch Sex Behav       Date:  1981-08

5.  Neutral 17beta-hydroxysteroid oxidoreductase deficiency in testes causing male pseudohermaphroditism in an infant.

Authors:  R A Harkness; D Thistlethwaite; J A Darling; N E Skakkeback; C S Corker
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

6.  Male pseudohermaphroditism: genetics and clinical delineation.

Authors:  J L Simpson
Journal:  Hum Genet       Date:  1978-10-19       Impact factor: 4.132

7.  Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy?

Authors:  Janet Chuang; Amy Vallerie; Lesley Breech; Howard M Saal; Shumyle Alam; Peggy Crawford; Meilan M Rutter
Journal:  Int J Pediatr Endocrinol       Date:  2013-09-12

8.  46,XY DSD with Female or Ambiguous External Genitalia at Birth due to Androgen Insensitivity Syndrome, 5alpha-Reductase-2 Deficiency, or 17beta-Hydroxysteroid Dehydrogenase Deficiency: A Review of Quality of Life Outcomes.

Authors:  Amy B Wisniewski; Tom Mazur
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.